{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:01:02Z","timestamp":1750737662536,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,22]]},"DOI":"10.7759\/cureus.86571","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:56:46Z","timestamp":1750661806000},"source":"Crossref","is-referenced-by-count":0,"title":["A Clinico-Epidemiological Study of Various Autoimmune Vesiculobullous Disorders in a Tertiary Care Center"],"prefix":"10.7759","author":[{"given":"Vunnava","family":"Sri Koulini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilipchandra","family":"Chintada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirankanth","family":"Vudayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Bathina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1363032","article-title":"State-of-the-art diagnosis of autoimmune blistering diseases","volume":"15","author":"van Beek N","year":"2024","unstructured":"van Beek N, Holtsche MM, Atefi I, et al.. State-of-the-art diagnosis of autoimmune blistering diseases. Front Immunol. 2024, 15:2. 10.3389\/fimmu.2024.1363032","journal-title":"Front Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1220887","article-title":"Janus kinase inhibitors in autoimmune bullous diseases","volume":"14","author":"Huang D","year":"2023","unstructured":"Huang D, Zhang Y, Kong L, Lu J, Shi Y. Janus kinase inhibitors in autoimmune bullous diseases. Front Immunol. 2023, 14:7. 10.3389\/fimmu.2023.1220887","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2021.0136","article-title":"Bullous autoimmune dermatoses-clinical features, diagnostic evaluation, and treatment options","volume":"118","author":"Beek NV","year":"2021","unstructured":"Beek NV, Zillikens D, Schmidt E. Bullous autoimmune dermatoses-clinical features, diagnostic evaluation, and treatment options. Dtsch Arztebl Int. 2021, 118:413-20. 10.3238\/arztebl.m2021.0136","journal-title":"Dtsch Arztebl Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.159620","article-title":"Pathophysiology of autoimmune bullous diseases: nature versus nurture","volume":"62","author":"Patel F","year":"2017","unstructured":"Patel F, Wilken R, Patel FB, et al.. Pathophysiology of autoimmune bullous diseases: nature versus nurture. Indian J Dermatol. 2017, 62:262-7. 10.4103\/0019-5154.159620","journal-title":"Indian J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.82385","article-title":"What is new in autoimmune vesicobullous disorders?","volume":"77","author":"Mahajan R","year":"2011","unstructured":"Mahajan R, De D. What is new in autoimmune vesicobullous disorders?. Indian J Dermatol Venereol Leprol. 2011, 77:407-12. 10.4103\/0378-6323.82385","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/life12040595","article-title":"Comorbidities in patients with autoimmune bullous disorders: hospital-based registry study","volume":"12","author":"S\u00e1nchez-Garc\u00eda V","year":"2022","unstructured":"S\u00e1nchez-Garc\u00eda V, P\u00e9rez-Alcaraz L, Belinch\u00f3n-Romero I, Ramos-Rinc\u00f3n JM. Comorbidities in patients with autoimmune bullous disorders: hospital-based registry study. Life (Basel). 2022, 12:5. 10.3390\/life12040595","journal-title":"Life (Basel)"},{"key":"ref7","article-title":"Bull\u00f8se hudsygdomme","volume":"184","author":"Kaae J","year":"2022","unstructured":"Kaae J, Bech R, Taudorf EH, Beck S, Vestergaard C, Ring HC, Jemec GB. Bull\u00f8se hudsygdomme. Ugeskr Laeger. 2022, 184:41.","journal-title":"Ugeskr Laeger"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-014-1531-1","article-title":"Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid","volume":"307","author":"Alpsoy E","year":"2015","unstructured":"Alpsoy E, Akman-Karakas A, Uzun S. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid. Arch Dermatol Res. 2015, 307:291-8. 10.1007\/s00403-014-1531-1","journal-title":"Arch Dermatol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20193121","article-title":"A retrospective study on clinical and demographic features of autoimmune vesiculobullous disorders from a rural tertiary care institute in Tamil Nadu","volume":"5","author":"Ramalingam R","year":"2019","unstructured":"Ramalingam R, Adaikalam Ganapathy VK, Chandrasekar SR, Narasiman B, Gounder DS. A retrospective study on clinical and demographic features of autoimmune vesiculobullous disorders from a rural tertiary care institute in Tamil Nadu. Int J Res Dermatol. 2019, 5:486-92. 10.18203\/issn.2455-4529.IntJResDermatol20193121","journal-title":"Int J Res Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-024-00277-7","article-title":"Epidemiological insights into autoimmune bullous diseases in China: a comprehensive analysis","volume":"14","author":"Chen Z","year":"2024","unstructured":"Chen Z, Wang L, Ma L, et al.. Epidemiological insights into autoimmune bullous diseases in China: a comprehensive analysis. J Epidemiol Glob Health. 2024, 14:513-23. 10.1007\/s44197-024-00277-7","journal-title":"J Epidemiol Glob Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000056","article-title":"Burden of pemphigus vulgaris with a particular focus on women: a review","volume":"8","author":"Kianfar N","year":"2022","unstructured":"Kianfar N, Dasdar S, Mahmoudi H, Daneshpazhooh M. Burden of pemphigus vulgaris with a particular focus on women: a review. Int J Womens Dermatol. 2022, 8:e056. 10.1097\/JW9.0000000000000056","journal-title":"Int J Womens Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae107","article-title":"Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment","volume":"191","author":"Strandmoe AL","year":"2024","unstructured":"Strandmoe AL, Bremer J, Diercks GF, et al.. Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment. Br J Dermatol. 2024, 191:164-76. 10.1093\/bjd\/ljae107","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2024.103264","article-title":"Maintenance treatment of pemphigus with rituximab in real life: a single-center study of 50 patients","volume":"151","author":"Louchez A","year":"2024","unstructured":"Louchez A, El Aarbaoui T, Weill A, et al.. Maintenance treatment of pemphigus with rituximab in real life: a single-center study of 50 patients. Ann Dermatol Venereol. 2024, 151:103264. 10.1016\/j.annder.2024.103264","journal-title":"Ann Dermatol Venereol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2006.47.2.278","article-title":"Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review","volume":"47","author":"Park SG","year":"2006","unstructured":"Park SG, Chang JY, Cho YH, Kim SC, Lee MG. Transition from pemphigus foliaceus to pemphigus vulgaris: case report with literature review. Yonsei Med J. 2006, 47:278-81. 10.3349\/ymj.2006.47.2.278","journal-title":"Yonsei Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74675","article-title":"Pemphigus foliaceus mimicking ichthyosis: a rare clinical presentation","volume":"16","author":"Ahmad A","year":"2024","unstructured":"Ahmad A, Al-Sughayer F, Shaban M, Al-Roomi S. Pemphigus foliaceus mimicking ichthyosis: a rare clinical presentation. Cureus. 2024, 16:e74675. 10.7759\/cureus.74675","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01354-8","article-title":"Epidemiology of malignant tumors in patients with pemphigus: an analysis of trends from 1955 to 2021","volume":"24","author":"Luo Y","year":"2024","unstructured":"Luo Y, Fei X, Wang M, et al.. Epidemiology of malignant tumors in patients with pemphigus: an analysis of trends from 1955 to 2021. Clin Exp Med. 2024, 24:100. 10.1007\/s10238-024-01354-8","journal-title":"Clin Exp Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2022.11.005","article-title":"Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study","volume":"98","author":"Fontenelle LF","year":"2023","unstructured":"Fontenelle LF, Bueno-Filho R, Vernal S, Delfino R, Barbosa GS, Donadi EA, Roselino AM. Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study. An Bras Dermatol. 2023, 98:774-80. 10.1016\/j.abd.2022.11.005","journal-title":"An Bras Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1481192","article-title":"Case report: a rollercoaster journey of pemphigus vegetans","volume":"15","author":"Hou X","year":"2024","unstructured":"Hou X, Chen J. Case report: a rollercoaster journey of pemphigus vegetans. Front Immunol. 2024, 15:1481192. 10.3389\/fimmu.2024.1481192","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2024.2428621","article-title":"The \"entanglement\" between bullous pemphigoid and diabetes mellitus: a comprehensive review and expert recommendations","volume":"21","author":"Li JH","year":"2025","unstructured":"Li JH, Zuo YG. The \"entanglement\" between bullous pemphigoid and diabetes mellitus: a comprehensive review and expert recommendations. Expert Rev Clin Immunol. 2025, 21:333-46. 10.1080\/1744666X.2024.2428621","journal-title":"Expert Rev Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00595-5","article-title":"Bullous pemphigoid","volume":"11","author":"Akbarialiabad H","year":"2025","unstructured":"Akbarialiabad H, Schmidt E, Patsatsi A, et al.. Bullous pemphigoid. Nat Rev Dis Primers. 2025, 11:12. 10.1038\/s41572-025-00595-5","journal-title":"Nat Rev Dis Primers"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12890\/2022_003160","article-title":"Esophageal bullous pemphigoid","volume":"9","author":"Castelo Branco C","year":"2022","unstructured":"Castelo Branco C, Fonseca T, Marcos-Pinto R. Esophageal bullous pemphigoid. Eur J Case Rep Intern Med. 2022, 9:60. 10.12890\/2022_003160","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.932356","article-title":"Atypical bullous pemphigoid after linagliptin intake","volume":"22","author":"Dbouk S","year":"2021","unstructured":"Dbouk S, Bazzi N, Saad WA, Toribio A, Habre M, Salloum A. Atypical bullous pemphigoid after linagliptin intake. Am J Case Rep. 2021, 22:e932356. 10.12659\/AJCR.932356","journal-title":"Am J Case Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101432","article-title":"Bullous pemphigoid: trigger and predisposing factors","volume":"10","author":"Moro F","year":"2020","unstructured":"Moro F, Fania L, Sinagra JL, Salemme A, Di Zenzo G. Bullous pemphigoid: trigger and predisposing factors. Biomolecules. 2020, 10:2. 10.3390\/biom10101432","journal-title":"Biomolecules"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.8483","article-title":"Rituximab in the treatment of epidermolysis bullosa acquisita: a systematic review of the literature","volume":"24","author":"Xenopoulou D","year":"2025","unstructured":"Xenopoulou D, Marson JW, Asrani F. Rituximab in the treatment of epidermolysis bullosa acquisita: a systematic review of the literature. J Drugs Dermatol. 2025, 24:387-93. 10.36849\/JDD.8483","journal-title":"J Drugs Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1214011","article-title":"Case Report: biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review","volume":"14","author":"Szyma\u0144ski K","year":"2023","unstructured":"Szyma\u0144ski K, Kowalewski C, Pietrzyk E, Wo\u017aniak K. Case Report: biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review. Front Immunol. 2023, 14:1214011. 10.3389\/fimmu.2023.1214011","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376193-a-clinico-epidemiological-study-of-various-autoimmune-vesiculobullous-disorders-in-a-tertiary-care-center","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:56:47Z","timestamp":1750661807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376193-a-clinico-epidemiological-study-of-various-autoimmune-vesiculobullous-disorders-in-a-tertiary-care-center"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,22]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.86571","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,22]]}}}